Salih, Teresita T.

HRN: 21-53-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/18/2022
07/25/2022
IV
4.5g IV
Q6h
Community-acquired Pneumonia, Medium-risk

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines